Topline data from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN expected by Q4 2025Anticipate completing enrollment in ...
Protein accumulations do important work in the human body, but something can go wrong and proliferate in those aggregates, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback